Name | Title | Contact Details |
---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
D F G Inc is a Ogden, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vi-Jon aims to offer our own branded products in particular specialized markets. Vi-Jon is proud to produce Germ-X, a leader among waterless antibacterial hand sanitizers.
A-Dec, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Newberg, OR. To find more information about A-Dec, Inc., please visit www.a-dec.com
Adena Health System offers a variety of Behavioral Health Services. Our mission is to assist each person in achieving the highest quality of life possible.